EUCTR2004-000509-24-IT进行中（未招募）不适用
A randomized active-controlled study of AMG 162 in breast cancer subjects with bone metastasis who have not previously been treated with bisphosphonate therapy.
AMGE0 个研究点目标入组 240 人开始时间: 2005年3月23日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 240
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
A randomised active controlled study of AMG 162 in breast cancer subjects with bone metastases who have not previously been treated with bisphosphonate therapyBone metastases of breast cancerEUCTR2004-000509-24-ATAmgen Inc240
进行中（未招募）
1 期
A randomised active controlled study of AMG 162 in breast cancer subjects with bone metastases who have not previously been treated with bisphosphonate therapyBone metastases of breast cancerEUCTR2004-000509-24-ESAmgen Inc240
进行中（未招募）
1 期
A randomised active controlled study of AMG 162 in breast cancer subjects with bone metastases who have not previously been treated with bisphosphonate therapyBone metastases of breast cancerEUCTR2004-000509-24-GBAmgen Inc240
未知
2 期
An Open-label, Multi-center, Phase 2 Study of AMG 162 (denosumab) in Subjects with Giant Cell Tumor of BoneGiant Cell Tumor of BoneJPRN-jRCT2080221624DAIICHISANKYO Co.,Ltd.10
进行中（未招募）
不适用
A Randomized, Phase 1b/2 Trial of AMG 102 or AMG 479 in Combination with Panitumumab versus Panitumumab Alone in Subjects with Wild-Type KRAS Metastatic Colorectal Cancer - 20060447wild-type KRAS metastatic colorectal cancerMedDRA version: 9.1Level: LLTClassification code 10052362Term: Metastatic colorectal cancerEUCTR2008-001751-21-ITAmgen Inc.144